4-78432433-C-G

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_025074.7(FRAS1):​c.5046C>G​(p.Asp1682Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00469 in 1,612,766 control chromosomes in the GnomAD database, including 24 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Uncertain significance in ClinVar.

Frequency

Genomes: 𝑓 0.0032 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0048 ( 24 hom. )

Consequence

FRAS1
NM_025074.7 missense

Scores

3
7
8

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:6

Conservation

PhyloP100: 2.28

Publications

7 publications found
Variant links:
Genes affected
FRAS1 (HGNC:19185): (Fraser extracellular matrix complex subunit 1) This gene encodes an extracellular matrix protein that appears to function in the regulation of epidermal-basement membrane adhesion and organogenesis during development. Mutations in this gene cause Fraser syndrome, a multisystem malformation that can include craniofacial, urogenital and respiratory system abnormalities. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2009]
FRAS1 Gene-Disease associations (from GenCC):
  • Fraser syndrome
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • Fraser syndrome 1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • renal agenesis, unilateral
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_025074.7, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.013111562).
BP6
Variant 4-78432433-C-G is Benign according to our data. Variant chr4-78432433-C-G is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 197043.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00319 (486/152318) while in subpopulation NFE AF = 0.00553 (376/68034). AF 95% confidence interval is 0.00507. There are 0 homozygotes in GnomAd4. There are 220 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 24 AD,AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_025074.7. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
FRAS1
NM_025074.7
MANE Select
c.5046C>Gp.Asp1682Glu
missense
Exon 38 of 74NP_079350.5
FRAS1
NM_001166133.2
c.5046C>Gp.Asp1682Glu
missense
Exon 38 of 42NP_001159605.1Q86XX4-5

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
FRAS1
ENST00000512123.4
TSL:5 MANE Select
c.5046C>Gp.Asp1682Glu
missense
Exon 38 of 74ENSP00000422834.2Q86XX4-2
FRAS1
ENST00000325942.11
TSL:1
c.5046C>Gp.Asp1682Glu
missense
Exon 38 of 42ENSP00000326330.6Q86XX4-5
FRAS1
ENST00000915768.1
c.5046C>Gp.Asp1682Glu
missense
Exon 38 of 73ENSP00000585827.1

Frequencies

GnomAD3 genomes
AF:
0.00319
AC:
486
AN:
152200
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000917
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00301
Gnomad ASJ
AF:
0.000865
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.000847
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00553
Gnomad OTH
AF:
0.00574
GnomAD2 exomes
AF:
0.00375
AC:
927
AN:
246912
AF XY:
0.00330
show subpopulations
Gnomad AFR exome
AF:
0.000916
Gnomad AMR exome
AF:
0.00532
Gnomad ASJ exome
AF:
0.00190
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00149
Gnomad NFE exome
AF:
0.00561
Gnomad OTH exome
AF:
0.00800
GnomAD4 exome
AF:
0.00485
AC:
7082
AN:
1460448
Hom.:
24
Cov.:
31
AF XY:
0.00475
AC XY:
3449
AN XY:
726354
show subpopulations
African (AFR)
AF:
0.000867
AC:
29
AN:
33458
American (AMR)
AF:
0.00544
AC:
242
AN:
44524
Ashkenazi Jewish (ASJ)
AF:
0.00107
AC:
28
AN:
26096
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39674
South Asian (SAS)
AF:
0.0000699
AC:
6
AN:
85882
European-Finnish (FIN)
AF:
0.00186
AC:
99
AN:
53362
Middle Eastern (MID)
AF:
0.00104
AC:
6
AN:
5768
European-Non Finnish (NFE)
AF:
0.00580
AC:
6449
AN:
1111350
Other (OTH)
AF:
0.00370
AC:
223
AN:
60334
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.451
Heterozygous variant carriers
0
353
706
1059
1412
1765
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
242
484
726
968
1210
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00319
AC:
486
AN:
152318
Hom.:
0
Cov.:
33
AF XY:
0.00295
AC XY:
220
AN XY:
74496
show subpopulations
African (AFR)
AF:
0.000914
AC:
38
AN:
41566
American (AMR)
AF:
0.00301
AC:
46
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.000865
AC:
3
AN:
3468
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5188
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4820
European-Finnish (FIN)
AF:
0.000847
AC:
9
AN:
10624
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00553
AC:
376
AN:
68034
Other (OTH)
AF:
0.00568
AC:
12
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
26
52
79
105
131
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00430
Hom.:
0
Bravo
AF:
0.00366
Asia WGS
AF:
0.000289
AC:
1
AN:
3478

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
3
not provided (3)
-
1
1
Fraser syndrome 1 (2)
-
-
1
FRAS1-related disorder (1)
-
-
1
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.94
BayesDel_addAF
Benign
-0.12
T
BayesDel_noAF
Uncertain
0.060
CADD
Benign
22
DANN
Uncertain
0.99
Eigen
Benign
-0.057
Eigen_PC
Benign
-0.044
FATHMM_MKL
Uncertain
0.96
D
LIST_S2
Benign
0.83
T
M_CAP
Benign
0.035
D
MetaRNN
Benign
0.013
T
MetaSVM
Benign
-0.69
T
MutationAssessor
Pathogenic
3.3
M
PhyloP100
2.3
PrimateAI
Uncertain
0.50
T
PROVEAN
Uncertain
-2.8
D
REVEL
Uncertain
0.35
Sift
Pathogenic
0.0
D
Sift4G
Benign
0.18
T
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
gMVP
0.56
Mutation Taster
=63/37
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs35219594;
hg19: chr4-79353587;
COSMIC: COSV105111699;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.